Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 2, 1999, Pages 102-107

  Backos, M ^a   Rai, R ^a   Baxter, N ^a   Chilcott, I T ^a   Cohen, H ^a   Regan, L ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIPYRETIC ANALGESIC AGENT; CARDIOLIPIN ANTIBODY; ENOXAPARIN; HEPARIN; HEPARIN CALCIUM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; CESAREAN SECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS HEART; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT ABORTION; SMALL FOR DATE INFANT; SUBCUTANEOUS DRUG ADMINISTRATION;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; CESAREAN SECTION; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDIES;

EID: 0032898875     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08208.x     Document Type: Note

References (30)

1. Rai RS, Regan L, Clifford K et al. Antiphospholipid antibodies and Beta2–glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995; 10: 2001–2005.
2. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73: 541–545.
3. Polzin WJ, Kopelman JN, Robinson RD, Read JA, Brady K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991; 78: 1108–1111.
4. Birdsall MA, Lockwood GM, Ledger WL, Johnson PM, Chamley LW. Antiphospholipid antibodies in women having in-vitro fertilization. Hum Reprod 1996; 11: 1185–1189.
5. Birdsall M, Pattison N, Chamley L. Antiphospholipid antibodies in pregnancy. Aust NZ J Obstet Gynecol 1992; 32: 328–330.
6. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829–834.
7. Hanly JG, Gladman DD, Rose TH, Laskin CA, Urowitz MB. Lupus pregnancy. A prospective study of placental changes. Arthritis Rheum 1988; 31: 358–366.
8. Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41: 179–186.
9. Di Simone N, Ferrazzani S, Castellani R, De Carolis S, Mancuso S, Caruso A. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 1997; 12: 2061–2065.
10. Di Simone N, De Carolis S, Lanzone A, Ronsisvalle E, Giannice R, Caruso A. In virro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormone-dependent human chorionic gonadotrophin release by cultured trophoblast cells. Placenta 1995; 16: 75–83.
11. Lyden TW, Vogt E, Ng AK, Johnson PM, Rote NS. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 1992; 22: 1–14.
12. Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993; 90: 64–67.
13. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10: 3301–3304.
14. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318–1323.
15. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993: 169: 1411–1417.
16. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584–1589.
17. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253–257.
18. Amout J, Spitz B, Wittevrongel C. Vanrusselt M, Van Assche, A. Vermylen J. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome. Thromh Haemosr 1994; 71: 741–747.
19. Carreras LO, Perez GN, Vega HR, Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2: 393.
20. Laskin CA, Bombardier C, Hannah ME et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. New Eng J Med 1997; 337: 148–153.
21. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
22. Khamashta MA, Hughes GR. ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies. J Clin Pathol 1993: 46: 104–107.
23. Nayar R, Lage JM. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature. Hum Pathol 1996; 27: 201–206.
24. Peaceman AM, Rehnberg KA. The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1993; 169: 1403–1406.
25. Rand JH, Wu X, Nemwerson Y. Deficiency of annexin-V (placental anticoagulant protein-I) on the surfaces of placental villi of women with antiphospholipid antibodies and recurrent abortion [abstract]. Thromb Hemostus 1993; 69: 953.
26. Rand JH, Wu XX, Andree HA et al. Pregnancy loss in the antiphospholipid-antibody syndrome – a possible thrombogenic mechanism. New Eng J Med 1997; 337: 154–160.
27. Peaceman AM, Rehnberg KA. The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant. Am J Obstet Gynecol 1995; 173: 1391–1396.
28. McIntyre JA, Taylor CG, Tomy DS, Wagenknecht DR, Wilson J, Faulk WP. Heparin and pregnancy in women with a history of repeated miscarriages. Haemostasis 1993; 23 (Suppl 1): 202–211.
29. Department of Health. NHS Maternity statistics, England: 1989–190 to 1994–1995: 1997.
30. Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 1996; 11: 1052–1060.